Alshomrany, A.; Miskeen, E.; Alfaifi, J.; Alshamrani, H.; Alshahrani, A. Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study. Med. Sci.2024, 12, 21.
Alshomrany, A.; Miskeen, E.; Alfaifi, J.; Alshamrani, H.; Alshahrani, A. Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study. Med. Sci. 2024, 12, 21.
Alshomrany, A.; Miskeen, E.; Alfaifi, J.; Alshamrani, H.; Alshahrani, A. Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study. Med. Sci.2024, 12, 21.
Alshomrany, A.; Miskeen, E.; Alfaifi, J.; Alshamrani, H.; Alshahrani, A. Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study. Med. Sci. 2024, 12, 21.
Abstract
Background: Maternal diabetes mellitus (MDM) is associated with increased risks for adverse neonatal outcomes. However, the impact of MDM on neonatal outcomes in Bisha, a city in Saudi Arabia, is not well-documented. This study aims to investigate the impact of MDM on neonatal outcomes in the Maternity and Children’s Hospital (MCH), Bisha, Saudi Arabia. Methods: A retrospective cohort study was conducted on 181 pregnant women with diabetes and their neonates diagnosed at Maternity and Children’s Hospital (MCH), Bisha, Saudi Arabia, between October 5, 2020, and November 5, 2022. The primary outcome was a composite of adverse neonatal outcomes, including stillbirth, neonatal death, macrosomia, preterm birth, respiratory distress syndrome, hypoglycemia, and congenital anomalies. Logistic regression analyses were used to adjust for potential confounders. Results: The total sample size was 181. The average age of patients was 34 years (SD=6.45). The majority of the patients were diagnosed with GDM, 147 (81.2%), and pre-GDM, 34 (18.8%). Neonates born to mothers with MDM had a higher risk of adverse neonatal outcomes compared to those born to mothers without MDM (adjusted odds ratio [aOR] = 1.46, 95% confidence interval [CI]: 1.25-1.70). The risks of macrosomia (aOR = 1.74, 95% CI: 1.38-2.19), LBW (aOR = 1.32, 95% CI: 1.06-1.66), and RDS (aOR = 1.57, 95% CI: 1.28-1.93) were significantly higher among neonates born to mothers with MDM. Types of DM were statistically significant with some neonatal outcomes: hypoglycemia (p-value = 0.017), macrosomia (p-value = 0.050), and neonatal death (p-value = 0.017). Conclusion: MDM is associated with an increased risk of adverse neonatal outcomes in Bisha. Early identification and management of MDM may improve neonatal outcomes and reduce the burden of neonatal morbidity and mortality in this population.
Keywords
Maternal diabetes mellitus; type 1 diabetes mellitus; type 2 diabetes mellitus; gestational diabetes mellitus; neonatal outcomes
Subject
Medicine and Pharmacology, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
